Mindray stock stood at CNY 166.00, 26.93 percent below target

Published on 10/12/2026 at 13:53 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Mindray stock was last at CNY 166.00 on October 12, 2026, up 2.85 percent. The 52-week high is CNY 239.99 and the next report is October 30, 2026.

Key points in brief

Mindray stock was last at CNY 166.00 on October 12, 2026, up 2.85 percent from CNY 161.40.
The stock remains 30.83 percent below its CNY 239.99 52-week high.
Investing.com lists a CNY 227.17 average analyst target and October 30, 2026, as the next earnings date.
Mindray's second-quarter 2026 revenue was CNY 9.4 billion and earnings per share were CNY 2.04.

Mindray, CNE100003G67, Illustration mit AI erstellt.

Mindray stock (ISIN CNE100003G67) was last at CNY 166.00 on October 12, 2026 at 3:04 p.m. CST, up 2.85 percent from the CNY 161.40 prior close. The price remains 26.93 percent below the CNY 227.17 average analyst target listed by Investing.com.

Price stays below yearly high

Mindray's latest quote is 30.83 percent below its CNY 239.99 52-week high and 27.10 percent above its CNY 130.66 low. Its market capitalization is CNY 201.3 billion, while the price-to-earnings ratio is 25.58 and the dividend yield is 0.03 percent.

The stock's valuation sits above the two comparison companies used here. Aier Eye Hospital Group was last at CNY 7.88, down 0.25 percent, with a price-to-earnings ratio of 27.89 and market capitalization of CNY 73.3 billion on October 12, 2026. Lepu Medical Technology was at CNY 11.72, up 0.34 percent, with a ratio of 27.96 and market capitalization of CNY 21.6 billion.

Comparison with peers

Mindray: plus 2.85 percent, P/E 25.58, market capitalization CNY 201.3 billion
Aier Eye Hospital Group (Shenzhen Stock Exchange, CNY): minus 0.25 percent, P/E 27.89, market capitalization CNY 73.3 billion
Lepu Medical Technology (Shenzhen Stock Exchange, CNY): plus 0.34 percent, P/E 27.96, market capitalization CNY 21.6 billion

Quarterly figures and valuation

In the second quarter of 2026, Mindray reported revenue of CNY 9.4 billion and earnings per share of CNY 2.04, versus revenue of CNY 9.28 billion and earnings per share of CNY 1.75 in the comparison figures listed by Investing.com. The same page lists 20 Buy ratings, no Hold ratings and no Sell ratings, alongside the CNY 227.17 average target.

On October 30, 2026, Mindray is scheduled to report its next earnings, according to Investing.com. That date gives the market a defined checkpoint after the latest price move.

Market context for Chinese shares

Mindray operates in healthcare equipment and supplies and is listed on the Shenzhen Stock Exchange under ticker 300760, according to Investing.com. The CNY 166.00 quote places the stock closer to its yearly low than its yearly high, while the CNY 227.17 target remains the main quantified valuation reference in current coverage.

Market context: Market report Shanghai Composite.